Dubai: dnata, one of the world's largest air services providers, has been certified by IATA's Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) for its pharma handling processes at its state-of-the-art cargo facility at Dubai World Central (DWC). The accreditation complements dnata's existing CEIV Pharma certification at Dubai International (DXB), demonstrating the company's ability to move pharmaceutical products under the strictest standards across its operations in the UAE.

In recent years dnata has significantly invested in infrastructure and equipment to enhance its pharma handling capabilities. The company's facilities at both DXB and DWC were designed with flexibility and unique product handling requirements in mind, taking advantage of the latest technologies. The cold storage areas in the cargo centres are modular, enabling teams to manage changing handling demands with dedicated climate control capability. Web-based monitoring systems are also in place to facilitate real-time management of all areas.

To ensure seamless delivery of temperature-sensitive goods from the warehouse to the aircraft, dnata launched 'cool dollies' in its operations. These high-tech containers were specially designed to serve the pharmaceutical industry with a closed temperature-controlled system.

In the financial year 2018-19 dnata handled 3,130 tons of pharmaceutical products at the two Dubai airports.

Bernd Struck, Senior Vice President, UAE Cargo & DWC Airline Services, dnata, said: "Air cargo has been playing an increasing role in the transportation of temperature-sensitive cargo, including pharmaceutical products. We constantly enhance our operations to meet the growing demand, and invest in cutting-edge technologies to provide the highest possible value to our customers. The achievement of the prestigious CEIV certification at our DWC cargo hub demonstrates the quality and reliability of our services."

Glyn Hughes, Global Head Cargo, IATA, said: "Improving industry logistics networks to achieve supply chain excellence increasingly requires transparency and cooperation amongst all supply chain partners to provide the high quality services customers demand to ultimately safeguard patient safety. We are delighted to recognize dnata's cargo facility at Dubai World Central (DWC) as an additional CEIV Pharma certified entity, raising the bar in the industry with a commitment to quality and continuous improvements. I congratulate dnata on this achievement."

The CEIV Pharma program was created by IATA to provide a globally consistent and recognized pharmaceutical product handling certification that focuses on airfreight and temporary storage. The stringent standards set by CEIV Pharma and the rigorous assessments conducted either meet or exceed many of the current worldwide regulations.

dnata's global commitment to providing best-in-class pharma handling services is underlined by the CEIV Pharma certification of its Amsterdam, Dallas, Dubai, Singapore and Toronto cargo centres, as well the GDP certification of its Amsterdam, London, Manchester, Singapore, and Zurich facilities.

A global air services provider and the trusted partner of over 300 airline customers, dnata offers ground handling, cargo and catering services at 127 airports in 19 countries.

Contact
Gabor Vasarhelyi
Public Relations
dnata
Phone: +971 4708 2144
Email: gabor.vasarhelyi@dnata.com 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.